One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Printed bands overlap at 30. Higher-frequency dosing is institutional. Some serious infections with CrCl <50 or IHD may instead use every-12-hour dosing after ID pharmacy review.
| CrCl, mL/min | Source-specific dose / instruction |
|---|---|
| >50 | 600 mg every 12 hours |
| 30-50 | 400 mg every 12 hours |
| 15-30 | 300 mg every 12 hours |
| <15 | 200 mg every 12 hours |
| CrCl, mL/min | Source-specific dose / instruction |
|---|---|
| >50 | 600 mg every 8 hours |
| 30-50 | 400 mg every 8 hours |
| 15-30 | 300 mg every 8 hours |
| <15 | 200 mg every 8 hours |
| Dialysis setting / indication | Source-specific schedule |
|---|---|
| IHD - first indication group | 200 mg every 12 hours |
| IHD - severe infection | 200 mg every 8 hours |
| Continuous HD - first indication group | 400 mg every 12 hours |
| Continuous HD - severe infection | 600 mg every 12 hours |
CrCl bands >50 / 30-50 / 15-30 / <15 mL/min correspond to IV doses 600 / 400 / 300 / 200 mg. For skin infection or community-acquired pneumonia with low MRSA risk, give every 12 hours. For severe infection or pneumonia with suspected/documented MRSA, this institutional regimen uses every 8 hours. The source overlaps at 30.
Intermittent HD: 200 mg every 12 hours for the first group or every 8 hours for severe infection. Continuous HD: 400 mg every 12 hours for the first group or 600 mg every 12 hours for severe infection. Some serious infections with CrCl <50 or IHD may use every-12-hour dosing after ID pharmacy review. The higher-frequency strategy is source-specific.
RDM30-041-ceftaroline-1 · Source locator: UCSF - ceftaroline: standard and severe-infection schedules; renal/dosing sections and stated qualifiers
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=ceftaroline&s1=RDM30-041-ceftaroline&h1=c7e310b5f80e6a5128f45525800b7c1cb9a76ac34ee57404d24ecc944911c528